Mef2d sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity
Di Giorgio, E., Wang, L., Xiong, Y., Akimova, T., Christensen, L. M., Han, R., Samanta, A., Trevisanut, M., Bhatti, T. R., Beier, U. H. and Hancock, W. W. Mef2d sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity. Journal Of Clinical Investigation. 2020. doi: 10.1172/jci135486
Read More